NGNE
#2631
Neurogene Inc. - Common Stock
38.3 6 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.29%
Changement Mensuel
+16.21%
Evolution sur 6 mois
+72.87%
Changement Annuel
+30.39%
Clôture Précédente
37.8 7
Open
38.3 6
Low
38.3 6
High
38.3 6
Volume
33
Financials
- Market Capitalization 767.64 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.25
ratio cours/chiffre d'affaires
2 346.93
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2620 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 23.92 USD | +3.73% | -4.43% | +24.20% | +274.33% | 779.35 M USD | ||
| 2621 |  AURA Aura Biosciences, Inc. - Common Stock | 7.50 USD | +0.94% | -2.60% | +6.08% | +18.30% | 777.79 M USD | ||
| 2647 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.26 USD | -1.38% | +5.59% | +4.40% | -22.70% | 749.14 M USD | ||
| 2650 |  ASMB Assembly Biosciences, Inc. - Common Stock | 36.72 USD | +4.38% | +2.31% | +43.83% | +24.79% | 747.64 M USD |